Breast

Article	Citations
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?	1949
No association between breast pain and breast cancer	192
Using Radio-Occult Lesion Localization (Roll) Techniques To Identify The Clipped Node In Targeted Axillary Dissections (Tad)	147
SBRT AND NEW RADIOTHERAPY TECHNIQUES FOR METASTATIC DISEASE	132
ADVANCED BREAST CANCER (ABC) PATIENT SUPPORT BY WEB CONFERENCING USING ZOOM	112
A PATIENT’S JOURNEY: BRIDGING THE GAP FROM METASTATIC BREAST CANCER DIAGNOSIS TO ACTIVE INVOLVEMENT AS A PEER NAVIGATOR	110
PO118 RESULTS OF ANTI-HER 2 THERAPIES AFTER BRAIN METASTASES ON THE PROGNOSIS IN BREAST CANCER PATIENTS	89
PO120 CAN A BREAST CANCER REGISTER MEASURE ADHERENCE TO NATIONAL ADVANCED BREAST CANCER (ABC) TREATMENT GUIDELINES IN CLINICAL PRACTICE?	80
Editorial Board	70
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?	68
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer	68
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer	63
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery	62
P203 Comparing the combine flap fixation and Harmonic scalpel technique with the Harmonic scalpel alone in reducing seroma formation after mastectomy in breast cancer patient: A pilot study for a RCT	60
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction	60
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience	55
PO136 IMPACT OF ISOLATED SOLITARY BREAST CANCER LIVER METASTASIS SURGICAL RESECTION ON COMMON PATIENT HEALTH STATUS AND ABILITY TO PROCEED CHEMOTHERAPY	52
Immediate breast reconstruction on overall and breast cancer-specific survival: A propensity score matched analysis	46
Novel models based on machine learning to predict the prognosis of metaplastic breast cancer	45
Sarcopenia in patients with metastatic breast cancer: A systematic review and meta-analysis	44
Unveiling the future of breast cancer therapy: Cutting-edge antibody-drug conjugate strategies and clinical outcomes	44
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines	43
P305: The SLIM Approach: Introducing a novelway for the orientation of cavity shaves during breast conserving surgery in breast cancer patients	41
P229: Impact of neoadjuvant chemotherapy on early relapses of luminal stage II breast cancer	40
P243: Partnership Between Breast Oncology Surgical Services and Hyperbaric Oxygen Therapy Unit Reduces Complications And Improves Outcomes	40

P332: Oncological Safety and Patient Satisfaction of Immediate Lipofilling in Breast-Conserving Surgery: A Systematic Reviewand Subgroup Meta-Analysis Comparing Outcomes with No Lipofilling	39
P279: Evaluation of Pathologic Complete Response (pCR) as a Surrogate for Event-Free Survival in neoadjuvant Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Early Breast Cancer (eBC)	36
P287: The Clinical efficacy of the ICG Fluorescence injection technique with blue dye for sentinel lymph node biopsy using dual injection technique in early breast cancer patients	36
P309: Four Grounds for Choosing Bilateral Free DIEP Flap Breast Reconstruction in Breast Cancer with Large and Ptotic Breasts: a retrospective case-control study	35
Editorial Board	34
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target	34
P473: Percutaneous Ultrasound-Guided Cryoablation for the Treatment of Breast Cancer in Non-Surgical Patients	34
Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers	34
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score	33
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study	33
Adenosquamous proliferation in radial sclerosing lesions: Histologic spectrum and key features in systematic review of 247 lesions	32
Optimising post-operative radiation therapy after oncoplastic and reconstructive procedures	32
Potential immune response to breast implants after immunization with COVID-19 vaccines	31
The continuing conundrum in oligometastatic breast carcinoma: A real-world data	31
Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis	30
Postoperative complications of hypofractionated and conventional fractionated radiation therapy in patients with implant-based breast reconstruction: A systematic review and meta-analysis	30
Cost-utility of talazoparib monotherapy treatment for locally advanced or metastatic breast cancer in Spain	30
Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer	29
Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cance	29
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study	29
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology	28
SA 2.4 Assessing clinical utility and clinical validity of biomarkers in clinical trials	28
Response to comment on: “Global guidelines for breast cancer screening: A systematic review”	28
P175 Characteristics and Survival Outcomes of Breast Cancer Patients Discussed at Molecular Tumor Board of European Institute of Oncology	28
Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective	28
P005 Impact of oral bacterial counts on febrile neutropenia during breast cancer chemotherapy	27
P097 Hypofractionated radiotherapy after neoadjuvant chemotherapy in Breast Cancer: Safety, feasibility, and early outcomes	27
P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outco	27
Therapeutic mammaplasty does not increase false positive findings on surveillance mammography and ultrasound	26
Editorial Board	26
PR137 CLINICALLY NODE NEGATIVE T4B BREAST CANCER IS A POOR INDICATION OF AXILLARY CLEARANCE: A SINGLE CENTRE EXPERIENCE	25
P264 The Comparison Outcome of Implant-based Breast Reconstruction with ADM, Non-ADM and TiLOOP Reconstruction in Breast Cancer Patients: A Case Series	25
FACTORS ASSOCIATED WITH ADVANCED PRESENTATION OF BREAST CANCER IN PAKISTAN	25
P242 Use of Acellular Pericardial Biological Mesh for Prepectoral and Dual Plane Prosthetic Breast Reconstruction Following Conservative Mastectomies	25
EFFICACY AND SAFETY PROFILE OF PALBOCICLIB AND FULVESTRANT IN PATIENTS ER+/HER2– METASTATIC BREAST CANCER OF A SINGLE ONCOLOGICAL CENTRE	25
Author Index	24
P279 A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice?	24
The long-term psychosocial consequences of screen-detected ductal carcinoma in situ and invasive breast cancer	23
PO75 A GLOBAL SURVEY OF YOUNG ADULTS LIVING WITH ALL STAGES OF BREAST CANCER WITH PARTICULAR INTEREST IN THOSE WITH METASTATIC BREAST CANCER, THEIR CO-SURVIVORS, AND THE HEALTHCARE PROVIDERS THAT CARE	23
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis	23
P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study	23
Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer	23
Reply to the letter: What can paintings teach us?	23
P061: Tumor-infiltrating lymphocytes and tertiary lymphoid structures are associated with a higher upstaging risk of ductal carcinoma in situ in breast biopsies	22
Early breast cancer in women aged 35 years or younger: A large national multicenter French population-based case control-matched analysis	22
Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, ran	22
A patient-led survey on information and communication needs of patients with metastatic breast cancer in Ireland and Northern Ireland (CTRIAL-IE 23–05)	22
P002: Genomic And Transcriptomic Profiling of Primary Tumors From Patients with HR+, HER2-, Node-positive, High-risk Early Breast Cancer (EBC) in the monarchE Trial	22
P018: Extended adjuvant (adj) neratinib in HER2+/HR+ early breast cancer (eBC) in clinical routine – interim analysis of the multinational, prospective, non-interventional study (NIS) ELEANOR (n = 300	22
P114: Evaluation of Sentinel Lymph Node by Sonography	21

P047: Clinicopathologic features and survival outcomes of metaplastic breast carcinoma patients: 20-year outcome results from an academic medical center in the United States	21
P028: Confronting Barriers in HER2-Positive Metastatic Breast Cancer: Insights from a Phase II Trial of Inetetamab, Pyrotinib, and Chemotherapy	21
P026: Prediction of response to anti-HER2 therapy using multigene assay	21
P040: Characterisation of Tropomyosin 3, a novel hypoxia induced gene, in Triple Negative Breast Cancer	21
P316: Clinical Management and Oncological Outcomes of Pure Pleomorphic and Florid Lobular Carcinoma in Situ of the Breast: Results fromthe MultiLCIS/OPBC International Multicentric Study	20
P390: Extreme Oncoplastic Breast Conservation surgery: Indications and techniques	20
P439: ELEGANT: Elacestrant vs Standard ET in Women and Men With Node-positive, ER+, HER2- Early Breast Cancer (eBC) With High Risk of Recurrence – A Global, Multicenter, Randomized, Openlabel Phase 3	20
P335: Indocyanine green angiography for preventing postoperative mastectomy complications in immediate breast reconstruction. Protocol study	20
Author Index	20
P280: Identifying Predictive Factors of Lymph Node Involvement in Stage I and II Luminal Breast Cancers to Optimize Neoadjuvant Chemotherapy Indication	20
P430: Design of a single-institution prospective observational study to evaluate the efficacy and tolerability of four-drug antiemetic therapy for anthracycline-based chemotherapy for early breast can	20
Oncoplastic and reconstructive surgery in SENONETWORK Italian breast centers: lights and shadows	19
Essential amino acids deprivation is a potential strategy for breast cancer treatment	19
Preoperative reference values for breast cancer patients using the BREAST-Q	19
P423: Breast cancer survivors and patients’ perspectives on supportive cancer care at the Peace and Love Hospitals in Ghana	19
Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis	19
PO148 A RANDOMIZED, CONTROLLED, PARALLEL-GROUP, TRIALON THE LONG-TERM EFFECTS OF MELATONIN ON FATIGUE ASSOCIATED WITH BREAST CANCER AND ITS ADJUVANT TREATMENTS	18
Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases	18
Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis	18
Diagnosis, biology and epidemiology of oligometastatic breast cancer	18
Are English-language online patient education materials related to breast cancer risk assessment understandable, readable, and actionable?	18
Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis	18
Treatment of oligometastatic breast cancer: The role of patient selection	18
Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival	17
Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled B	17
Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making	17
Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer?	17
The impact of breast density notification on psychosocial outcomes in racial and ethnic minorities: A systematic review	17
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased r	17
Switching to T-DM1 remains justified in patients with HER2-negative residual invasive breast cancer after neoadjuvant therapy	17
Psychoeducation for breast cancer: A systematic review and meta-analysis	17
P168 OncotypeDX RS new TAILORx cut-offs: omitting Chemotherapy in more patients aged >50 years with Early Breast Cancer	16
P281 The effect of Chinese culture on family planning of Childbearing age women with breast cancer in North China	16
P161 The updated PREDICT breast cancer prognostication in 91, 182 patients using Korean Breast Cancer Registry Data	16
SA 2.3 Multi-omic machine learning prediction of treatment response	16
P293 Classification of abnormal findings on dedicated breast PET for prediction of malignancy	16
P189 Impact assessment of sentinel lymph node core needle biopsy guided by ultrasound for node-positive breast cancer patients	15
P117 Axillary residual disease after neoadjuvant treatment according to disease burden in the sentinel lymph node biopsy	15
P095 Ultra-hypofractionated adjuvant radiotherapy in very elderly ratients with early breast cancer	15
P105 Internal mammary chain irradiation in breast cancer patients: Which patterns of practice between controversial benefit and challenging dosimetry?	15
P065 High satisfaction of women in Slovenian breast cancer screening program DORA: results of an anonymous survey	15
P187 Comparison of long term oncologic outcome of sentinel lymph node mapping methods, dye-only versus dye and radioisotope in breast cancer following neoadjuvant chemotherapy	15
Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer	14
Is circulating tumor cell count-driven cost-effective for first-line therapy choice in HR+/HER2- metastatic breast cancer in the United States?	14
P041: Distinguishing Second Ipsilateral Locoregional Breast Cancer as True Recurrence or New Primary: A Comparison of Clinicopathological Classification and Molecular Clonality Analysis	14
Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC)	14
A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in Germany	14
Additional intraoperative subpectoral plane block vs conventional pain control: A comparison of shoulder movement in patients with mastectomy	14
Interactive multidisciplinary pilot workshop to improve medical student perception of and interest in breast surgical oncology	14
The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa	14
Rates of reoperation after breast conserving cancer surgery in Western Australia before and after publication of the SSO-ASTRO margins guideline	14
P029: The contribution of the double blockade “Pertuzumab – Trastuzumab” in neo-adjuvant situation in localized Her2 positive Breast Cancers (Algerian experience)	14
P160: The effectiveness of trastuzumab emtansine (TDM1) in metastatic breast cancer based on the duration of response to adjuvant HER2-targeted therapy	13
P111: Cost-effectiveness of a breast cancer screening program in Switzerland	13
P432: Exploring the Role of Precision Medicine in Adjuvant Systemic Therapy for Early-stage Breast Cancer: A Prospective Cohort Study	13
Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial	13
P336: Sentinel Lymph Node Biopsy: Retrospective Analysis of Prognostic and Predictive Factors to Assess the Omission of Axillary Surgery	13
P242: Global disparities in breast cancer treatment – an international survey	13
P186: Post-mastectomy radiotherapy negatively impacts short-term patient-reported outcomes in patients with and without immediate reconstruction – a retrospective cohort study	13
P284: Navigating Physical and Emotional Challenges After Mastectomy Without Reconstructive Surgery: A Study in Rural India	13
P441: Breaking Barriers: Addressing Delayed Breast Cancer Diagnosis in Rural India through Cultural Sensitivity and Gender-Specific Care	13
Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database	13
P075: The Benefits of comprehensive NGS Panels using Liquid Biopsy in Breast Cancer	13
P181: Acute and Late Toxicity after Hypofractionated Radiotherapy in Breast Cancer Patients Received Neoadjuvant Chemotherapy-Experience of our Department	13
P343: Surgical management of positive margins after breast conservative surgery: 5-years monoistitutional records with 5-years follow-up	13
P427: Exploring Treatment Adherence and Unmet Needs of Older Breast Cancer Patients in Nigeria	13
Copyright Page	13
Trends in axillary surgery and clinical outcomes among breast cancer patients with sentinel node metastasis	12
BP52 DEVELOPMENT OF AN INFORMATION FILM FOR FRIENDS AND FAMILY OF PATIENTS WITH MBC “THEY JUST DON’T KNOW WHAT TO SAY OR DO”	12
Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study	12
Uptake of bilateral-risk-reducing-mastectomy: Prospective analysis of 7195 women at high-risk of breast cancer	12
P162 Contralateral Breast Cancer in BRCA 1 vs 2 Mutation Carriers	12
Macrophage density is an adverse prognosticator for ipsilateral recurrence in ductal carcinoma in situ	12
Cost-effectiveness of abbreviated-protocol MRI screening for women with mammographically dense breasts in a national breast cancer screening program	12
Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer	12
P208 Contrast-enhanced ultrasound using intradermal microbubble sulfur hexafluoride for identification of sentinel lymph nodes during breast cancer surgery: a clinical trial	12
PO104 COMPARING EFFICACY AND TOXICITY IN HR+/HER2- METASTATIC BREAST CANCER PATIENTS TREATED WITH RIBOCICLIB OR PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY: RESULTS FROM A SINGLE CENTER IN MEXIC	12
Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race	12
Cognitive function is well preserved in a cohort of breast cancer survivors: Roles of cognitive reserve, resilience, and general health	12
The role of vacuum assisted excision in diagnosis of papillary lesions without atypia	12

SA 5.2 Risk assessment in ER positive disease: Who should receive CDK 4–6 inhibitors?	11
P016 Patient Characteristics, Treatment and Long-term Outcomes from a Real-World Population of Early Breast Cancer Patients at High risk of Recurrence in Scotland	11
P003 ROSE trial: A prospective non-interventional study to assess the quality of life (QoL) of premenopausal patients with early breast cancer receiving triptorelin as ovarian function suppression	11
The Design And Development Of an Individualised Training Program For Metastatic Breast Cancer (MBC) Nursing Incorporating Remote And Onsite Learning Experiences During A Pandemic	11
BP132 LOCAL HERO: A PHASE II STUDY OF LOCAL THERAPY ONLY (STEREOTACTIC RADIOSURGERY AND/OR SURGERY) FOR TREATMENT OF UP TO 5 BRAIN METASTASES FROM HER2+ BREAST CANCER. (TROG STUDY 16.02)	11
P211 Surgical treatment for elderly patients with ductal carcinoma in situ. Is it still a safety and valid option?	11
P043 Characteristics and clinical outcomes of patients with HER2-low breast cancer	11
PO143 MODELING AN ANNOUNCEMENT PATHWAY FOR PATIENTS ENTERING METASTATIC DISEASE CLINICAL ISSUES: SUPPORTIVE AND PALLIATIVE CARE	11
Does mammographic density predict survival in women with invasive breast cancer? The need to account for potential confounding from cancer stage and overdiagnosis	11
P133 Immunohistochemical expression of estrogen receptors after neoadjuvant chemotherapy in breast cancer	11
P215 Absent post-treatment changes in negative sentinel lymph nodes and regional recurrence in initially node positive breast cancer patients	11
P085 Target axillary disecction in cN2 breast cancer patients after neoadjuvant chemotherapy. Preliminary results	11
On top of that all, now Covid-19, too. A scoping review of specificities and correlates of fear of cancer recurrence in breast cancer patients during COVID-19	11
Skin perfusion and oxygen saturation after mastectomy and radiation therapy in breast cancer patients	11
P346: Pre-operative MRI vs. no MRI in patients with ductal carcinoma in situ treated at two oncology centers in Lima, Peru (2016–2023): A real-world data analysis	10
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life	10
P356: New Method for Nipple-Areolar Complex Reconstruction with FixNip - Nipple Reconstruction Implant (FixNip NRI™): A Preliminary Study	10
IN24 AI SUPPORTING PATIENT-CENTRIC HEALTHCARE LEARNING	10
PO91 A LIQUID BIOMARKER REFLECTING PROLIFERATION RATE - THYMIDINE KINASE ACTIVITY - PROVIDES UNIQUE GUIDANCE FOR PREDICTING THERAPY EFFICACY AND MONITORING OF ADVANCED BREAST CANCER	10
BP48 WHAT IS A LIFE WITH MBC WORTH? THE CANCER CURRENCY CAMPAIGN: DEMANDING EQUITABLE TREATMENT FOR THOSE LIVING WITH METASTATIC BREAST CANCER	10
PO65 PSYCHOLOGICAL AND RELIGIOUS COPING STRATEGIES IN MOROCCAN WOMEN RECENTLY DIAGNOSED WITH LOCALLY ADVANCED BREAST CANCER: BASELINE FINDINGS FROM COHORT STUDY	10
P226: Real world evidence of neoadjuvant chemotherapy without anthracyclines in triple-negative breast cancer among Mexican patients	10
P032: Brown adipocytes are more capable than ASC in promoting breast cancer invasiveness through cell fusion	10
P299: A Systematic Cavity-Saving Technique for Reducing Margin Positivity in Breast-Conserving Surgery: A Cost-Effective Alternative to Frozen Section Biopsy (CSRP Study)	10
Poster Session	10
THE IMPACT OF RESIDUAL AXILLARY BURDEN AND LYMPHO-VASCULAR INVASION POST-NEOADJUVANT CHEMOTHERAPY ON OUTCOME IN LOCALLY ADVANCED BREAST CANCER	10
P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?	10
P306: Comparison of oncological outcomes of Breast Reconstruction, Breast-Conserving, and Mastectomy Surgery in Breast Cancer Patients Undergoing Neoadjuvant Treatment: A Propensity Scorematched Analy	10
IN25 WHEN SHOULD THE PRIMARY TUMOR BE TREATED IN ABC?	10
P374: Comparison of Radioguided Occult Lesion Localization (ROLL) and Magnetic Marker Techniques for Preoperative Localization of Non-Palpable Breast Lesions in Breast-Conserving Surgery	10
P134: Eligibility for bilateral prophylactic mastectomy: an expert opinion study in the Netherlands	10
Chemotherapy in older patients with early breast cancer	10
PR125 EARLY RELAPSE OF HER2 POSITIVE BREAST CANCER	10
P283 Overall survival of patients treated for breast cancer: about 124 cases	10
P265 Cryoablation in Breast Cancer Care - an analysis from a Single Multi-Disciplinary Unit in Southern Africa	10
Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period	9
Efficacy of antiandrogens in androgen receptor-positive triple-negative metastatic breast cancer: Real-life data	9
Management of HR+/HER2+ lobular breast cancer and trends do not mirror better outcomes	9
Multimodal data integration in early-stage breast cancer	9
Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer	9
The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: A systematic review	9
P240: Mapping cancer care trajectories: Treatment and service lived experiences of women with breast cancer	9
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy	9
Association of clinicopathologic variables and patient preference with the choice of surgical treatment for early-stage breast cancer: A registry-based study	9
Quality indicators for breast cancer care: A systematic review	9
Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data	9
The early Monash experience with targeted axillary dissection: lessons, pitfalls and practice patterns	9
Breast and axillary surgery after neoadjuvant systemic treatment – A review of clinical routine recommendations and the latest clinical research	9
Survival of south african women with breast cancer receiving anti-retroviral therapy for HIV	9
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC	9
“Alas … my sickness becomes my family's burden”: A nested qualitative study on the experience of advanced breast cancer patients across the disease trajectory in Indonesia	9
Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study	9
Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico	9
The features of male breast cancer in China: A real-world study	8
PO84 LESSONS LEARNED IN DEVELOPING A TREATMENT ACCESS PROGRAM FOR ADVANCED BREAST CANCER IN LOW- AND MIDDLE-INCOME COUNTRIES	8
IN1 THE SPARK THAT LIT THE FIRE - LILLIE’S JOURNEYS WITH ABC PATIENTS AND THEIR FAMILIES	8
P238 Is BCT safer than Mastectomy for the treatment of early breast cancer?	8
P167 Prediction of Axillary lymph node metastasis by Tumor to breast ratio in breast cancer	8
SA 10.3 Breast cancer treatment and research from an African perspective	8
The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients	8
P089: MammaTyper test as a predictive biomarker of neoadjuvant chemo-immunotherapy response in patients with estrogen receptor (ER) low HER2 negative breast cancer	8
P415: Sleep quality and influencing factors among tunisian breast cancer patients	8
Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients	8
Automated coronary artery calcium scoring in patients with breast cancer to assess the risk of heart disease following adjuvant radiation therapy	8
IDENTIFIYING OPPORTUNITIES TO IMPROVE PATH TO DIAGNOSIS OF DE NOVO MBC IN YOUNG WOMEN	8
REAL WORLD EFFECTIVENESS AND QUALITY OF LIFE OF RIBOCICLIB AND LETROZOLE IN ADVANCED BREAST CANCER	8
P230 Breast reconstruction: recurrence in patients with mastectomy and immediate breast reconstruction	8
P155 Exploration of specific population for adjuvant capecitabine escalation therapy in early-stage triple-negative breast cancer: a retrospective biological sample analysis of the CBCSG010 clinical t	8
A NATIONAL STUDY OF THE EXPERIENCES, INFORMATION NEEDS AND ATTITUDES TO CLINICAL RESEARCH OF PATIENTS LIVING WITH SECONDARY BREAST CANCER IN THE UK	8
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis	8
P074: Epithelial-Mesenchymal Transition Markers Expression in Male Breast Cancer	8
P208: Use of MammaTyperin predicting response to neoadjuvant therapy in HER2-positive breast cancer	8
Mondor's disease of the breast: A cutaneous thromboembolic manifestation of Covid-19?	8
P476: Evaluation of Short-Term Postoperative Pain in Breast Surgery Patients using Regional Technique as an Adjuvant	8
CANNABINOIDS AND ADVANCED BREAST CANCER PATIENTS	8
PO82 PERSPECTIVES OF FEMALE HIGH SCHOOL STUDENTS IN GHANA, NAMIBIA, MALAWI AND ZAMBIA: HOW LACK OF ACCESS TO HOLISTIC CANCER CARE FUELS ADVANCED BREAST CANCER IN AFRICA	8
Contralateral Breast Cancer: Influence Of Molecular Subtype, Clinical Features And Treatment Given In A Single Institution Study	8
PO69 CAPTURING LIFE IN COLOR: DOCUMENTING THE LIVED EXPERIENCES OF ADVANCED BREAST CANCER PATIENTS	8
P049 Investigating the pathogenesis of poor-outcome Triple-Negative Breast Cancer	8
P370: The Alexisretractor in axillary surgery for breast cancer: a preliminary study on reducing surgical complications and enhancing surgical efficiency	8
P012: 5-year vs 10-year Hormone Therapy: Comparison of Recurrence in Patients with Luminal A and Luminal B Breast Cancer	8
P451: Participation of a breast cancer patient in the multidisciplinary team - from decision making to changing the treatment option	8
P178: Ultra-hypofractionated Breast Radiotherapy in patients receiving Systemic Treatment: A risky combination?	7
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer	7
P361: Locoregional treatment of multi-metastatic breast cancer	7
P138: Impact of Awareness Campaigns on Breast Cancer Diagnosis: A Retrospective Study	7
Efficacy and safety of PARP inhibitors in patients with BRCA-mutated advanced breast cancer: A meta-analysis and systematic review	7
Reproductive risk factors associated with breast cancer in young women by molecular subtype	7
Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial	7
P354: Modified oncoplastic surgery techniques for the management of central breast tumors: a case series	7
P057: TLD-1, a Second-Generation Nano-Liposomal Doxorubicin, in Patients with Advanced Breast Cancer from the Dose Escalation and Expansion Phase 1 Study (SAKK 65/16)	7
Climate change impacts and sustainability integration among breast international group members	7
Improving medication adherence to endocrine therapy in breast cancer patients: a mixed-methods systematic review of effective communication strategies for healthcare providers	7
Progression-free survival and quality of life in metastatic breast cancer: The patient perspective	7
P418: Administration of GnRH agonists during neoadjuvant therapy - single institution experience	7